MARKET · WASHINGTON, DC
DC’s cannabis market: where it stands and where it’s headed by 2029
Washington, DC has one of the most unusual cannabis markets in the country. Here’s how it got here, what it looks like today, and what the next three years could bring.
October 2026 · 4 min read
How DC got here
In 2014, DC voters approved Initiative 71. It lets adults 21 and older possess up to two ounces of cannabis, grow it at home and give up to an ounce to another adult. What it didn’t create was a legal way to buy it. Since 2015, a congressional budget rider, known as the Harris rider, has barred the District from using its own funds to regulate and tax recreational sales.
That gap produced a “gifting” economy: shops that sold a sticker, a T-shirt or a juice and “gifted” cannabis with it. At its peak, the gray market counted more than 200 storefronts.
The District’s answer has been to grow its legal medical program. A 2022 law let adults 21 and older self-certify for a medical cannabis card without a doctor’s recommendation. Later reforms gave gifting shops a path into the licensed system and handed the Alcoholic Beverage and Cannabis Administration (ABCA) new enforcement powers.
Where the market stands now
The legal market is growing fast. Monthly sales across DC’s medical program passed $10 million for the first time in April 2026, more than double the low point of about $3.9 million in September 2024.
Registrations have surged. DC counted about 131,000 registered patients by June 2026, up from roughly 30,000 at the start of 2025, driven largely by self-certification.
The gray market is shrinking. Since ABCA gained enforcement powers in 2024, the District has closed more than 100 unlicensed shops, and about 95 former gifting businesses have moved into the licensed system. Roughly 68 licensed retailers, including delivery-only operators, were serving the market in early 2026.
Growth isn’t even. Registrations have run well ahead of active, repeat buyers. Tourist traffic has softened, and several categories, including vapes, edibles and pre-rolls, have seen declines.
What to watch over the next three years
1. Congress and the Harris rider. As long as the rider stays in federal spending bills, DC can’t launch a taxed adult-use market, so the medical program, with self-certification, remains the main legal channel. If Congress drops it, the District already has a regulator and licensed operators in place to move quickly. The rider has been renewed every year since 2015, so neither outcome is a safe bet.
2. Federal rescheduling. In April 2026, the DEA moved marijuana handled under state medical licenses to Schedule III. A broader rescheduling decision is still pending after hearings this summer. For licensed medical operators, Schedule III could ease the heavy federal tax burden cannabis businesses have long carried, improving margins across the market.
3. A more mature, more competitive market. With fewer unlicensed storefronts and more licensed retailers, expect sharper competition on price and quality, some consolidation among smaller operators, and growing weight on local cultivation and brands customers recognize.
The likely picture by 2029
The most likely outcome is a larger, more formal DC market still built on the medical framework, with fewer gray-market storefronts and tighter margins for operators. The wild card is Congress. If the District is allowed to regulate adult-use sales, the market could expand quickly. If not, growth will come from bringing more of today’s demand into the licensed system.